| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $6.4M | -2.6% |
| SG&A Expense | $56.7M | +3.2% |
| Pre-tax Income | -$289.2M | -186.2% |
| Income Tax | -$79K | -112.2% |
| Net Income | -$289.1M | -184.3% |
| EPS (Basic) | -$1.75 | -182.3% |
| EPS (Diluted) | -$1.75 | -177.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.7M | -78.6% |
| Inventory | $8.1M | +68.8% |
| Current Assets | $53.9M | -66.9% |
| Total Assets | $798.4M | -23.2% |
| Current Liabilities | $90.9M | +63.4% |
| Total Liabilities | $617.9M | -0.2% |
| Stockholders' Equity | $180.4M | -57.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$144.8M | -52.6% |
| Capital Expenditures | $55.6M | -63.9% |
| Investing Cash Flow | -$7.0M | +93.1% |
| Financing Cash Flow | -$109.2M | -140.1% |
| Free Cash Flow | -$200.4M | +19.5% |